Clinical Trial Update: Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial assessing lacosamide as adjunctive therapy in young children (1 month to <4 years) with partial-onset seizures; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy with Partial Onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy With Partial-onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2021-07-01